MannKind | MNKD - EPS Earnings Per Share


MannKind reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -0.01 0.01 0.07 Nov/05
FY2026Q2 Jun/2026 -0.01 -0.01 0.05 Aug/05
FY2026Q1 Mar/2026 -0.02 -0.01 0.07 May/06
FY2025Q4 Dec/2025 0.01 0.01 0.08 Feb/26
FY2025Q3 Sep/2025 0.07 0.02 0.06 Nov/05




Eps Change Date
Adma Biologics USD 0.16 0.03 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Insmed USD -0.46 0.4 Sep/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD 0.31 0.89 Jun/2026
MannKind USD -0.01 0 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD 0.13 0.59 Dec/2025
Novo Nordisk DKK 0.96 9.95 Jun/2026
Pfizer USD 0.87 0.1 Sep/2026
Sanofi EUR 3.55 1.46 Sep/2026
Xencor USD 0.5 0.79 Sep/2026